Trial Profile
A Study to Evaluate the Optimal Sequencing of Enzalutamide and Abiraterone in Men With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 31 Mar 2016
Price :
$35
*
At a glance
- Drugs Abiraterone acetate (Primary) ; Enzalutamide (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 31 Mar 2016 New trial record